Search - tctmd.com

Displaying 81 - 100 of 124

Sort: Relevancy | Date

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

News Daily News

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

Jason Kahn

May 15, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

Yael L. Maxwell

April 24, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

News Daily News

HORIZONS-AMI: El Daño Renal Durante una PCI Primaria está Estrechamente asociado al Pronóstico

March 20, 2014

News Daily News

SCAI提出围术期心梗新定义

November 01, 2013

News Daily News

SCAI Proposes New Definition for Periprocedural MI

November 01, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

Current Choice of Antiplatelet Therapies in NSTEMI and STEMI

Presenter: Roxana Mehran

October 28, 2013

Presentation TCT 2013

Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter?

Presenter: Roxana Mehran

October 28, 2013

News Daily News

高风险亚组从瑞舒伐他汀中获得肾脏保护

Caitlin E. Cox

October 11, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

Presentation TCT 2013

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Presenter: Joe Dizon, Sorin Brener, Akiko Maehara, Bernhard Witzenbichler, Jacek Godlewski, Helen Parise, Jan-Henk Dambrink, Roxana Mehran, C. Michael Gibson, Gregg Stone

January 31, 2013

Presentation TCT 2013

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Presenter: David Planer, E. Magnus Ohman, Harvey White, Jeffrey Moses, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Advertisement

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

The Data Strongly Support Bivalirudin!

Non-Access Site Bleeds After PCI More Dangerous Than Access Site Bleeds

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

HORIZONS-AMI: El Daño Renal Durante una PCI Primaria está Estrechamente asociado al Pronóstico

SCAI提出围术期心梗新定义

SCAI Proposes New Definition for Periprocedural MI

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Current Choice of Antiplatelet Therapies in NSTEMI and STEMI

Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter?

高风险亚组从瑞舒伐他汀中获得肾脏保护

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial

Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content